|
|
|
Press Release: The Pharmaceutical Compliance Forum's Eighteenth Pharmaceutical and Medical Device Compliance Congress Features Compliance and Ethics Consideration in R&D
|
- Sponsored by the Pharmaceutical Compliance Forum
- November 6 - 8, 2017
- Onsite at the Mandarin Oriental, Washington, DC
- Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com |
EARLY BIRD REGISTRATION
-- SAVE UP TO $400 --
|
Register by Friday, September 22, 2017 and save up to $400.
Click here to register.
|
|
|
FEATURING COMPLIANCE AND ETHICS CONSIDERATIONS IN R&D BY
|
David Cromley, JD
Associate Vice President, Merck, Philadelphia, PA |
Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ
|
Michelle Shwery, MSc, MBA
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN |
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Former Interim Chief Compliance Officer, Misonix, Inc., West Chester, PA
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 9, 2017: The Pharmaceutical Compliance Forum's Eighteenth Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 6 - 8, 2017 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
|
KEYNOTE SPEAKERS
|
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD |
Charles Cain, Esq.
Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC |
Susan Dentzer
President and Chief Executive Officer, NEHI (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC
|
Colin M. Huntley, JD
Assistant Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC |
Pablo Quiñones, JD
Chief, Strategy, Policy and Training Unit, Fraud Section, Criminal Division, US Department of Justice, Former Assistant United States Attorney in the Criminal Division, US Attorney’s Office for the Southern District of New York, Washington, DC |
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
|
James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York, Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration, Former, NY Medicaid Inspector General, Former Associate United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, New York, NY |
Darryl Wegner, JD
Unit Chief, International Corruption Unit, FBI, Washington, DC
|
|
|
CO CHAIRS
|
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Chicago, IL |
Matthew D'Ambrosio, JD, MBA
Senior Vice President, Chief Compliance and Ethics Officer, Sunovion Pharmaceuticals Inc., Chair, Pharmaceutical Compliance Forum, Marlborough, MA |
Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ
|
Jeffrey Kawalek, MBA
Senior Director, Ethics & Compliance, North America, Ipsen Biopharmaceuticals, Inc., New York, NY |
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD |
Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi, US, Bridgewater, NJ
|
|
|
FEATURED FACULTY
|
Thomas W. Beimers, Esq.
Partner, Hogan Lovells, Former Senior Counsel for Administrative and Civil Remedies, Office of the Inspector General, Department of Health and Human Services, Minneapolis, MN |
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC
|
David Cromley, JD
Associate Vice President, Merck, Philadelphia, PA |
Michelle Drozd, ScM
Deputy Vice President, Policy and Research, Pharmaceutical Research & Manufacturers of America (PhRMA), Washington, DC |
Jacob T. Elberg
Chief, Health Care and Government Fraud Unit, United States Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ
|
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY |
Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells LLP, Former Executive Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA |
Gejaa T. Gobena, JD
Partner, Hogan Lovells, Former Deputy Chief, Fraud Section, Criminal Division, Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC
|
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC |
Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC |
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC
|
Jason Mehta, JD
Assistant US Attorney, United States Attorney's Office Middle District of Florida, US Department of Justice, Jacksonville, FL |
Michael A. Morse, JD
Partner, Pietragallo, Gordon, Alfano, Bosick & Raspanti, Former Assistant District Attorney, Philadelphia District Attorney's Office, Philadelphia PA |
Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC
|
Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ |
Gregg Shapiro, JD
Assistant US Attorney, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA |
Michelle Shwery, MSc, MBA
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN
|
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA, Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC |
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Former Interim Chief Compliance Officer, Misonix, Inc., West Chester, PA
|
|
|
2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.International PharmaCongress.com
|
|
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.Asian PharmaCongress.com
|
|
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Spring 2018
Mumbai, India
Coming Soon
|
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
|
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
|
2012 - São Paulo
2013 - Madrid
2013 Kuala Lumpur
2014 - Dubai
|
2014 - Mexico City
2015 - Manila
2016 - Warsaw
2017 - Lisbon
|
|
|
|
|
SPONSORED BY
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
GRANTORS:
|
|
PLATINUM
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNERS:
|
|
|
CONTINUING EDUCATION CREDITS:
|
Accounting Professionals: Pending approval for NASBA CPE credits.
Attorney Credits: Pending Approval for PA MCLE credits.
Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.
Click here for more information.
|
|
PARTICIPATION OPTIONS
|
|
TRADITIONAL ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
LIVE AND ARCHIVED WEBCAST PARTICIPATION
|
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office
|
|
WEBCAST INTERFACE SAMPLE
|
Click here for a sample stream
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
PHARMA CONGRESS IS
|
|
|
|
|
|
